Genomatix Now Offers mDECOY Kinase Kits.ROANOKE, Va. -- Genomatix Corporation has announced the availability of mDECOY(TM) Kinase kits containing vector combinations that are "built-to-order" based on researcher specifications. Kinase targets, subcellular sub·cel·lu·lar adj. 1. Situated or occurring within a cell: subcellular organelles. 2. Smaller in size than ordinary cells: subcellular organisms. 3. locations, and other mDECOY(TM) vector options can now be selected and ordered online at http://www.genomatix.com. Each mDECOY(TM) vector drives expression of a kinase-specific, mutant substrate decoy DECOY. A pond used for the breeding and maintenance of water-fowl. 11 Mod. 74, 130; S. C. 3 Salk. 9; Holt, 14 11 East, 571. that can be localized to a specific subcellular domain. Knockdown of kinase activity is caused by competitive inhibition competitive inhibition n. Blockage of the action of an enzyme on its substrate by replacement of the substrate with a similar but inactive compound that can combine with the active site of the enzyme but that is not acted upon or split by the enzyme. between the mutant decoy protein and the wild-type substrate of the targeted kinase. Intracellular localization Customizing software and documentation for a particular country. It includes the translation of menus and messages into the native spoken language as well as changes in the user interface to accommodate different alphabets and culture. See internationalization and l10n. is accomplished through fusion of a localization signal that concentrates the knockdown within a selected subcellular domain. "There is growing evidence that a kinase often resides in multiple subcellular locations, either concurrently or transiently, and that phenotypic effects often differ based upon the location of its activity," said Thomas Reed Thomas Reed may refer to:
tr.v. des·tined, des·tin·ing, des·tines 1. To determine beforehand; preordain: a foolish scheme destined to fail; a film destined to become a classic. 2. , which may cause confusing results or toxic effects. Our mDECOY(TM) method minimizes interference with other location-dependent interactions by localizing a post-translational mutant substrate inhibitor to a specific subcellular domain." Genomatix has chosen a "build-to-order" kit approach because of the large combinatorial spectrum associated with mapping and characterizing many different location-dependent kinase effects. According to Robert Beech, Genomatix CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , "There are over 500 identified kinases and hundreds of unique subcellular locations across many different cell types. Given the large number of potential combinations and research applications, we determined it was best to use our modular production system to assemble vector combinations on a per-order basis. Our online ordering system has a starting set of mutant substrate decoys and subcellular locations that can be selected to create hundreds of different mDECOY(TM) vector combinations. Additional mutant substrates and localization signals are in product development and will be added to the online ordering system over time. If needed, our Custom Services group can handle special requirements that fall outside the available online options." Genomatix specializes in the production of subcellular modulation vectors. Its modular UltraVector(TM) system and NucleoBank(TM) components enable rapid combinatorial production of mDECOY(TM) vectors. Additional information about Genomatix is located on the company's website at www.genomatix.com. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion